Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Asenbaum

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Journal of Sleep Research|September 30, 2000
Excessive daytime sleepiness in patients suffering from different levels of obstructive sleep apnoea syndromeC Sauter, S Asenbaum, R Popovic, et al.
Nuclear Medicine Communications|April 6, 2004
Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleepG G Tribl, S Asenbaum, S Happe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2002
European Association of Nuclear Medicine procedure guidelines for brain perfusion SPET using (99m)Tc-labelled radiopharmaceuticalsK Tatsch, S Asenbaum, P Bartenstein, et al.
Biological Psychiatry|February 9, 2000
Seasonal variation of availability of serotonin transporter binding sites in healthy female subjects as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomographyA Neumeister, W Pirker, M Willeit, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2002
European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligandsK Tatsch, S Asenbaum, P Bartenstein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2002
European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligandsK Tatsch, S Asenbaum, P Bartenstein, et al.
Medical & Biological Engineering & Computing|July 9, 1999
Application of correlation dimension and pointwise dimension for non-linear topographical analysis of focal onset seizuresM Feucht, U Möller, H Witte, et al.
Neuroradiology|April 11, 2002
Sequential MRI in a case of Creutzfeldt-Jakob diseaseG G Tribl, G Strasser, J Zeitlhofer, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsyT Brücke, S Asenbaum, W Pirker, et al.
Advances in Neurology|January 1, 1993
Dopamine D2 receptor imaging and measurement with SPECTT Brücke, S Wenger, S Asenbaum, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Journal of Sleep Research|September 30, 2000
Excessive daytime sleepiness in patients suffering from different levels of obstructive sleep apnoea syndromeC Sauter, S Asenbaum, R Popovic, et al.
Nuclear Medicine Communications|April 6, 2004
Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleepG G Tribl, S Asenbaum, S Happe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2002
European Association of Nuclear Medicine procedure guidelines for brain perfusion SPET using (99m)Tc-labelled radiopharmaceuticalsK Tatsch, S Asenbaum, P Bartenstein, et al.
Biological Psychiatry|February 9, 2000
Seasonal variation of availability of serotonin transporter binding sites in healthy female subjects as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomographyA Neumeister, W Pirker, M Willeit, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2002
European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligandsK Tatsch, S Asenbaum, P Bartenstein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2002
European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligandsK Tatsch, S Asenbaum, P Bartenstein, et al.
Medical & Biological Engineering & Computing|July 9, 1999
Application of correlation dimension and pointwise dimension for non-linear topographical analysis of focal onset seizuresM Feucht, U Möller, H Witte, et al.
Neuroradiology|April 11, 2002
Sequential MRI in a case of Creutzfeldt-Jakob diseaseG G Tribl, G Strasser, J Zeitlhofer, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsyT Brücke, S Asenbaum, W Pirker, et al.
Advances in Neurology|January 1, 1993
Dopamine D2 receptor imaging and measurement with SPECTT Brücke, S Wenger, S Asenbaum, et al.
Pageof 7